MKMalte Kuniss

Malte Kuniss

*This is an algorithmically generated author record based on publicly available information.

Malte Kuniss has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Score Associated with the Outcome after Multiple Ablation Procedures in Patients with Atrial Fibrillation

    by Maciej Wójcik, Alexander Berkowitsch, Sergey Zaltsberg, Christian W. Hamm, Heinz F. Pitschner, Malte Kuniss, Thomas Neumann

    Background Catheter ablation (CA) of atrial fibrillation (AF) is now established therapeutic option. Multiple procedures (MPs) are often needed to achieve the satisfactory outcome. The aim of the study was to assess the outcome after MPs in AF patients categorized to risk‐score groups. Methods We followed a cohort of consecutive 911 (69% male; median 59 years) patients with AF (58% paroxysmal) who had CAAF performed. ALARMEC (Atrial fibrillation type, Left Atrium size, Renal insufficiency, MEtabolic syndrome, cardiomyopathy) risk score was calculated for each patient. The end point was maintenance of sinus rhythm at the follow‐up of 60 months. Results We performed 1,199 CAAF procedures. One, two, and three procedures were performed in 663 (73%), 208 (23%), and 40 (4%) patients, respectively. Outcome after the first procedure (56%) was improved with MPs (76%). MPs > 2 were performed in 1%, 3%, 5%, 6%, and 10% patients with ALARMEC score of 0, 1, 2, 3, and 4, respectively. MPs were successful in 89%, 86%, 81%, 65%, and 43% of patients with ALARMEC score of 0, 1, 2, 3, and 4, respectively. Outcome in 174 (19%) patients on antiarrhythmic drugs (AADs) was 85%, 68%, 75%, 44%, and 39% in ALARMEC score: 0, 1, 2, 3, and 4, respectively. Outcome in 737 (81%) patients without AAD was 90%, 85%, 80%, 77%, and 69% in ALARMEC score of 0, 1, 2, 3, and 4, respectively. Conclusion The moderate success rate after index procedure of CAAF can be further improved with multiple ones and AAD.


  • P-Wave Terminal Force and Atrial Fibrillation: A Lesson Learned From Old Masters

    by Maciej Wojcik, Malte Kuniss, Alexander Berkowitsch, Thomas Neumann

    • 1 January 2012
      • Vol. 70  (6) , 549-54

    Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation.

    by Maciej Wójcik, Malte Kuniss, Alexander Berkowitsch, Sergey Zaltsberg, Sebastien Janin, Andrzej Wysokiński, Christian W Hamm, Heinz F Pitschner, Thomas Neumann

    Radiofrequency (RF) current is used as a common energy source to perform pulmonary vein isolation (PVI) in patients with atrial fibrillation. We applied measurements of the blood concentration of cTnI as a surrogate parameter for the injured cell mass. To clarify which parameters are major determinants of myocardial injury, estimated by cTnI, after PVI with RF ablation. The study population consisted of 82 consecutive patients in whom PVI with RF ablation was performed. In 41 patients, additional linear lesions (LL) were needed. Blood samples were obtained during venous puncture before a procedure and a further one, six and 24 hours after ablation. Pathological cTnI values were observed in all patients in the first hour and further increased in time. The median of peak cTnI value in the LL group was significantly (p 〈 0.05) higher than the respective value in patients without LL made: 1.16 (0.85;1.98) and 0.94 (0.65;1.14) ng/mL, respectively. Significantly higher cTnI values (p = 0.043) were observed in patients who maintained sinus rhythm in long term follow-up. The only independent predictor of myocardial injury after PVI with RF ablation, expressed as an increase in cTnI level, is cumulative energy applied. The larger the myocardial injury, the greater the PVI effectiveness.


    • 1 January 2011
      • Vol. 69  (11) , 1151-5

    Which standard biomarkers are useful for the evaluation of myocardial injury after pulmonary vein isolation with cryoballoon?

    by Maciej Wójcik, Sebastien Janin, Thomas Neumann, Malte Kuniss, Alexander Berkowitsch, Damir Erkapic, Sergey Zaltsberg, Katherina Madlener, Andrzej Wysokiński, Christian W Hamm, et al.

    Many studies have used creatinine kinase (CK), myocardial bound for CK (CK-MB), and cardiac troponin I (cTnI) and T (cTnT) to evaluate myocardial cells injury after ablation. We applied measurements of the blood concentration of cardio-specific biomarkers as surrogates for the injured cell mass. To clarify which of the standard biomarkers are useful in the evaluation and quantification of lesions produced by cryoballoon ablation (CBA) during pulmonary vein isolation. The CBA was performed in 33 patients with atrial fibrillation. Blood samples were obtained before CBA and one, six, and 24 h after CBA. We analysed CK, CK-MB and cTnI. A significant increase of all biomarkers was observed at each hour of collection as compared to the baseline measurement. Maximum median peak levels occurred at 6 h. Pathological values of CK, CK-MB and cTnI were observed in 94%, 100% and 100% of patients, respectively. Both maximum CK and CK-MB values correlated with median temperature (p < 0.05) reached during CBA. Additionally, CK-MB correlated with total cryo-time (p < 0.03). The CK-MB is the best biochemical marker for the evaluation of myocardial injury after CBA. The cTnI can be useful as an additional parameter of myocardial injury after CBA.


  • Contributors

    by Bernard Albat, Jesús Almendral, Robert Anders, Peter S. Andrew, Mauricio S. Arruda, Samuel J. Asirvatham, Felipe Atienza, Koji Azegami, Alex Babkin, Alessandro Barbone, et al.

  • Acute Success and Persistence of Bidirectional Conduction Block in the Cavotricuspid Isthmus One Month Post Cryocatheter Ablation of Common Atrial Flutter

    by Malte Kuniss, Klaus Kurzidim, Harald Greiss, Alexander Berkowitsch, Johannes Sperzel, Christian Hamm, Heinz Friedrich Pitschner

    Introduction: Cryoablation is successful in the treatment of common atrial flutter. Long‐term clinical success is mainly dependent on persistence of bidirectional conduction block (BCB) in the inferior cavotricuspid isthmus (CTI). Only few data on persistence of BCB post cryoablation with the reported technique are available. This prospective study aimed to test efficacy of cryo energy and persistence of BCB in the CTI 1 month post cryoablation. Methods: Cryoablation of the CTI was performed in 50 consecutive patients (64 ± 12 years, 40 males) with symptomatic common atrial flutter using a novel 9 Fr 8‐mm‐tip catheter. BCB in the CTI 30 minutes following the final cryoapplication was the ablation endpoint. Thirty days post ablation, persistence of BCB was controlled by repeat electrophysiological study (EPS). Results: In all patients BCB was achieved with a mean of 9 (IQR 7–17.5) cryo applications and a mean cryo time of 2,378 seconds (IQR 1,680–3,474 seconds). In 5 of 50 patients, common atrial flutter recurred within 1 month post cryoablation. In 30 of 32 recurrence‐free patients, persistence of BCB was verified. In 2 patients, resumption of isthmus conduction was detectable. Including relapses, 81.1% of patients (30/37) showed persistence of BCB. No patients reported pain during cryoapplication. No procedural complications were observed. Conclusions: Cryoablation of the CTI using a large‐tip catheter is feasible and safe in the treatment of common atrial flutter. Acute and short‐term success rates are comparable to those reported for radiofrequency (RF) ablation. Besides short‐term clinical success, the persistence of BCB demonstrates efficacy of the cryoablation technique.